• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,623
2,051
2,047
1,709
1,518

COUNTRY

995
814
243
235
194

CATEGORIES

  • 858
  • 185
  • 123
  • 317
  • 458
  • 230
  • 254
  • 65
  • 76
  • 793
  • 1,399
  • 855
  • 24
  • 409
  • 1,278
  • 2,246
  • 25
  • 266
  • 0
  • 49

PRICE

5,018
10,433
19,454
25,485

PUBLISHED

3,598
5,292
9,420
25,485

PRODUCT TYPE

21,433
1,950
957
877
164
37
21
21
18
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Algeria Pharmaceuticals and Healthcare Report Q2 2014

BMI View: In addition to the Algerian government's favourable policies towards attracting foreign investment, this quarter has seen two further indications of the country's drive to rapidly expand the...

February 2014

Kenya Pharmaceuticals and Healthcare Report Q2 2014

BMI View: It is vital that companies that are looking to sell non-communicable disease therapeutics work alongside the public sector and focus on physician education and patient awareness in a market...

February 2014

Antibody Drug Conjugates: Contract Manufacturing Market, 2014 – 2024

The concept of Antibody drug conjugates (ADCs) is simple - a cytotoxic / chemotherapy drug is delivered to the target tissue through linking it with a monoclonal antibody. However, the practical challenge...

February 2014
FROM

The Corporate Reputation of Pharma in 2013 —the Patient Perspective

A Global Survey of The Views of 800 Patient Groups On the Corporate Reputation of the Pharma Industry as a Whole and 33 Leading Pharma Companies A benchmarking strategy for corporate patient centricity...

February 2014
FROM

Practical Sustainability Strategies. How to Gain a Competitive Advantage

Strategies that enable organizations to succeed as businesses and as responsible corporate citizens Based on the authors' many years of research and hands-on experience, this book provides tested...

February 2014

Product and Pipeline Analysis of the Global Parkinson's Disease Therapeutics Market

This research service focuses on existing therapeutics and product pipeline for the treatment of Parkinson’s Disease using Dopamine Replacement Therapies, Dopamine Agonists, MAO-inhibitors, COMT-inhibitors...

February 2014
FROM

High Throughput Screening (HTS) Market by Technology, Applications & by End Users - Forecast to 2018

'High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology,...

February 2014
FROM
Stakeholder Perspectives: Innovation within the Biopharma Industry Stakeholder Perspectives: Innovation within the Biopharma Industry - Product Thumbnail Image

Stakeholder Perspectives: Innovation within the Biopharma Industry

What does innovation mean within the biopharma industry? How much you spend on R&D? How many products you bring to market? How many New Molecular Entities (NME) you have in research? Within the biopharma...

February 2014
FROM

Cancer Molecular Diagnostics: Suppliers Market Report 2014

Cancer diagnostics is one of the most dynamic medical fields, reflecting efforts to translate new advances in cancer into improved tests and treatments Increasingly, researchers and clinicians pursue...

February 2014
FROM

Cancer Molecular Diagnostics: Market Developments, Growth Areas and Opportunities 2014

Cancer diagnostics is one of the most dynamic medical fields, reflecting efforts to translate new advances in cancer into improved tests and treatments Increasingly, researchers and clinicians pursue...

February 2014
FROM
Life Sciences BPO Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Life Sciences BPO Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 - Product Thumbnail Image

Life Sciences BPO Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

'Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics)and...

February 2014
FROM

Australia Pharmaceuticals and Healthcare Report Q1 2014

BMI View: We maintain our broad view toward Australia's pharmaceutical and healthcare sectors, as new Prime Minister Tony Abbott stated that 'there will be no cuts to health' While the country's ageing...

February 2014
HIV - KOL Insight and Consensus Outlook Modules HIV - KOL Insight and Consensus Outlook Modules - Product Thumbnail Image

HIV - KOL Insight and Consensus Outlook Modules

What do frontline clinicians really think about current HIV treatment pathways and what are the most pressing unmet needs that industry can respond to? What's driving long term growth in HIV? The market...

February 2014
FROM

US Cancer Vaccine Market Outlook 2018

Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments Therapeutic cancer vaccines and Prophylactic cancer vaccines are the...

February 2014
FROM

US Orphan Drug Market Outlook 2018

In the largest market for orphan drugs, USA, there was a shortage of adequate therapies for treating many rare diseases These therapies were not developed as companies did not expect these drugs to...

February 2014
FROM
Value-driven Pharma: Integrating Health Outcomes across the Product Lifecycle Value-driven Pharma: Integrating Health Outcomes across the Product Lifecycle - Product Thumbnail Image

Value-driven Pharma: Integrating Health Outcomes across the Product Lifecycle

Two recessions in a decade, financial austerity, and unprecedented pressure to prove product value to all stakeholders There is no question that the pharma game has changed in the new “Outcomes Era”,...

February 2014
FROM

Europe Orphan Drug Market Outlook 2018

The concept of rare diseases and the idea that a special attention needs to be given to this sector has been taking shape in Europe since the 1990s ever since then the political aspects and initiatives...

February 2014
FROM

Dietary Supplements Market in CIS Countries 2014 - Development Forecasts for 2014-2018

Explore the prospects for dietary supplement sales in Russia, Ukraine and Kazakhstan with this in-depth report Which Commonwealth of Independent States (CIS) country has the highest capacity for expansion...

February 2014
FROM

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world Since 2010, affected by the new GMP certification and other factors, the revenue and total profit...

February 2014
FROM
China Pharmaceutical Equipment Industry Report, 2013-2016 China Pharmaceutical Equipment Industry Report, 2013-2016 - Product Thumbnail Image

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world Since 2010, affected by the new GMP certification and other factors, the revenue and total profit...

February 2014
FROM
Loading Indicator

Our Clients

Our clients' logos